Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Evaluating the Communication Between Patients and Providers in Cancer Clinics

for
Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT06985953

Recruiting

Partner4Exercise Study

for
Cancer
Location: Hamilton
Sponsor: McMaster University

Sex: All

Age: 60+

Code: NCT07408128

Phase 2, Phase 3, Recruiting

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

for
Malignant Neoplasm
Location: Sherbrooke, New York NY, Hackensack NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06979596

Phase 2, Recruiting

Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer

for
NSCLC, Locally Advanced
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT06865339

Phase 2, Recruiting

Clinical and Genetic Studies of Li-Fraumeni Syndrome

for
Li-Fraumeni Syndrome, Neoplasms, Tp53 Mutations
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT01443468

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Raleigh NC, Tampa FL, Detroit MI, St Louis MO,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06974110

Phase 1, Recruiting

Intravital Microscopy in Human Solid Tumors

for
Solid Tumor, Adult, Clinical Stage IV Gastric Cancer AJCC v8,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03823144

Recruiting

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

for
Follicular Lymphoma, Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06108232

Phase 2, Recruiting

A Study of Herbal Supplements in Cancer Survivors With Constipation

for
Constipation, Cancer, Functional Constipation
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07091084

Recruiting

Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.

for
Leukemia
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles

Sex: All

Age: 3+

Code: NCT06360718

Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: New Haven CT, Lake Success NY, New York NY, Teaneck NJ,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase 2, Phase 3, Recruiting

Support for Bereaved Cancer Caregivers

for
Bereavement, Cancer, Caregiver, Grief
Location: East Lansing MI
Sponsor: Michigan State University

Sex: All

Age: 18+

Code: NCT06662409

Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Durham NC, Cleveland OH,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase 1, Recruiting

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

for
Malignancy, Immune Related Adverse Events
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 0+

Code: NCT06789601

Phase 1, Phase 2, Recruiting

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Hackensack NJ, Fairfax VA, Madison WI, Houston TX
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06598800

Phase 1, Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: New York NY, New Brunswick NJ, Morristown NJ,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase 1, Recruiting

Integrated Cancer Repository for Cancer Research

for
Pancreatic Cancer, Thyroid Cancer, Lung Cancer,
Location: Manchester CT, Holyoke MA, Glens Falls NY, Utica NY,
Sponsor: University of Nebraska

Sex: All

Age: 19 - 70+

Code: NCT02012699

Recruiting

Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer

for
Advanced Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07105033

Recruiting

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

for
Blood Cancer, Leukemia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06469307

Recruiting

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Lebanon NH, New Hyde Park NY, New York NY, Buffalo NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06997029

Phase 1, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial